ReCardia LLC

ReCardia is a research-stage life sciences company developing novel medical devices for treating the heart and blood vessels. Cardiovascular diseases are the leading cause of death and disability worldwide having a major economic burden and impact on the healthcare delivery system. Our mission is to advance products that improve the quality of life for people suffering from heart diseases. Our market is the expanding field of interventional pericardiology. Recent research has indicated the importance of the pericardium and pericardial fluid on cardiac function. ReCardia plans to create inventive tools that target and enrich pericardial fluid for heart repair therapies. Our business strategy is to build strong long-term, mutually beneficial relationships with forward-thinking investors, industry partners and academic institutions.